Ribomic Inc. (TYO:4591)
97.00
+6.00 (6.59%)
At close: Mar 6, 2026
Ribomic Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 2,100 | 1,837 | 2,099 | 2,825 | 2,901 | 3,338 |
Short-Term Investments | 1,100 | 1,200 | 1,300 | 1,500 | 1,800 | 2,500 |
Cash & Short-Term Investments | 3,200 | 3,037 | 3,399 | 4,325 | 4,701 | 5,838 |
Cash Growth | 3.09% | -10.65% | -21.41% | -8.00% | -19.48% | 191.90% |
Accounts Receivable | 0.83 | - | - | - | - | - |
Other Receivables | 43.86 | 50 | 64 | 70 | 59 | 36 |
Receivables | 44.69 | 50 | 64 | 70 | 59 | 36 |
Inventory | 3.45 | 3 | 2 | 2 | 2 | 3 |
Prepaid Expenses | 37.44 | 29 | 27 | 36 | 21 | 18 |
Other Current Assets | 41.96 | 28 | 14 | 109 | 125 | 155 |
Total Current Assets | 3,328 | 3,147 | 3,506 | 4,542 | 4,908 | 6,050 |
Property, Plant & Equipment | 6.03 | - | - | - | - | 30 |
Long-Term Investments | 50.29 | 38 | 40 | 41 | 46 | 38 |
Other Long-Term Assets | 0 | - | 1 | - | - | 1 |
Total Assets | 3,384 | 3,185 | 3,547 | 4,583 | 4,954 | 6,119 |
Accounts Payable | 83.87 | - | - | - | - | 1 |
Accrued Expenses | 17.59 | 11 | 12 | 12 | 12 | 11 |
Current Income Taxes Payable | 11.29 | 109 | 98 | 155 | 212 | 82 |
Other Current Liabilities | 48.17 | 22 | 45 | 32 | 36 | 22 |
Total Current Liabilities | 160.93 | 142 | 155 | 199 | 260 | 116 |
Other Long-Term Liabilities | 0 | - | 1 | - | 1 | 1 |
Total Liabilities | 160.93 | 142 | 156 | 199 | 261 | 117 |
Common Stock | 872.38 | 401 | 63 | 722 | 238 | 6,542 |
Additional Paid-In Capital | 5,157 | 4,685 | 4,348 | 5,315 | 6,139 | 6,515 |
Retained Earnings | -2,806 | -2,043 | -1,024 | -1,653 | -1,684 | -7,055 |
Comprehensive Income & Other | 0.55 | - | 4 | - | - | - |
Shareholders' Equity | 3,223 | 3,043 | 3,391 | 4,384 | 4,693 | 6,002 |
Total Liabilities & Equity | 3,384 | 3,185 | 3,547 | 4,583 | 4,954 | 6,119 |
Net Cash (Debt) | 3,200 | 3,037 | 3,399 | 4,325 | 4,701 | 5,838 |
Net Cash Growth | 3.09% | -10.65% | -21.41% | -8.00% | -19.48% | 191.90% |
Net Cash Per Share | 67.93 | 75.14 | 95.23 | 139.03 | 167.28 | 227.05 |
Filing Date Shares Outstanding | 54.31 | 44.59 | 36 | 35.69 | 28.55 | 27.87 |
Total Common Shares Outstanding | 54.31 | 44.59 | 36 | 35.69 | 28.55 | 27.87 |
Working Capital | 3,167 | 3,005 | 3,351 | 4,343 | 4,648 | 5,934 |
Book Value Per Share | 59.35 | 68.24 | 94.19 | 122.84 | 164.37 | 215.37 |
Tangible Book Value | 3,223 | 3,043 | 3,391 | 4,384 | 4,693 | 6,002 |
Tangible Book Value Per Share | 59.35 | 68.24 | 94.19 | 122.84 | 164.37 | 215.37 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.